[British Medical Journal Publishing Group 25th EAHP Congress, 25thâ27th March 2020, Gothenburg, Sweden - ()] Section 5: Patient Safety and Quality assurance - 5PSQ-062â Effectiveness of adalimumab in inflammatory bowel disease and influence of response to firstline treatment
Gil-Sierra, MD, Briceño-Casado, MDP, Rios-Sanchez, E, Dominguez-Cantero, M, Borrero-Rubio, JMDOI:
10.1136/ejhpharm-2020-eahpconf.379
Fichier:
PDF, 53 KB